Image_1_Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood.pdf
The CSF-470 cellular vaccine plus BCG and rhGM-CSF increased distant metastases-free survival in cutaneous melanoma patients stages IIB-IIC-III relative to medium dose IFN-α2b (CASVAC-0401 study). Patient-045 developed a mature vaccination site (VAC-SITE) and a regional cutaneous metastasis (C-MTS), which were excised during the protocol, remaining disease-free 36 months from vaccination start. CDR3-TCRβ repertoire sequencing in PBMC and tissue samples, along with skin-DTH score and IFN-γ ELISPOT assay, were performed to analyze the T-cell immune response dynamics throughout the immunization protocol. Histopathological analysis of the VAC-SITE revealed a highly-inflamed granulomatous structure encircled by CD11c+ nested-clusters, brisk CD8+ and scarce FOXP3+, lymphocytes with numerous Langhans multinucleated-giant-cells and macrophages. A large tumor-regression area fulfilled the C-MTS with brisk lymphocyte infiltration, mainly composed of CD8+PD1+ T-cells, CD20+ B-cells, and scarce FOXP3+ cells. Increasing DTH score and IFN-γ ELISPOT assay signal against the CSF-470 vaccine-lysate was evidenced throughout immunization. TCRβ repertoire analysis revealed for the first time the presence of common clonotypes between a VAC-SITE and a C-MTS; most of them persisted in blood by the end of the immunization protocol. In vitro boost with vaccine-lysate revealed the expansion of persistent clones that infiltrated the VAC-SITE and/or the C-MTS; other persistent clones expanded in the patient's blood as well. We propose that expansion of such persistent clonotypes might derive from two different although complementary mechanisms: the proliferation of specific clones as well as the expansion of redundant clones, which increased the number of nucleotide rearrangements per clonotype, suggesting a functional antigenic selection. In this patient, immunization with the CSF-470 vaccine plus BCG and rhGM-CSF induced a T-cell repertoire at the VAC-SITE that was able to infiltrate an emerging C-MTS, which resulted in the expansion of a T-cell repertoire that persisted in blood by the end of the 2-year treatment.
History
References
- https://doi.org//10.1038/nature00766
- https://doi.org//10.1056/NEJMoa1103782
- https://doi.org//10.1016/S0140-6736(12)60868-X
- https://doi.org//10.1093/annonc/mdx176
- https://doi.org//10.1056/NEJMoa1408868
- https://doi.org//10.1056/NEJMoa1708539
- https://doi.org//10.21037/atm.2017.06.09
- https://doi.org//10.1084/jem.182.2.459
- https://doi.org//10.1002/j.1460-2075.1992.tb05481.x
- https://doi.org//10.1056/NEJMoa1504030
- https://doi.org//10.1016/S0140-6736(16)32517-X
- https://doi.org//10.1056/NEJMoa1802357
- https://doi.org//10.1038/nature13954
- https://doi.org//10.3389/fimmu.2017.00625
- https://doi.org//10.3389/fimmu.2018.02531
- https://doi.org//10.3389/fimmu.2018.00955
- https://doi.org//10.1097/01.cji.0000208258.79005.5f
- https://doi.org//10.3389/fimmu.2013.00098
- https://doi.org//10.1002/path.1906
- https://doi.org//10.3389/fimmu.2015.00144
- https://doi.org//10.4049/jimmunol.178.5.3161
- https://doi.org//10.1002/path.2092
- https://doi.org//10.1006/cimm.1998.1352
- https://doi.org//10.3389/fimmu.2017.01342
- https://doi.org//10.1158/1078-0432.CCR-14-3073
- https://doi.org//10.1097/DAD.0b013e3181b34a19
- https://doi.org//10.1097/00002371-200001000-00004
- https://doi.org//10.1158/1078-0432.CCR-16-2680
- https://doi.org//10.1186/s12896-017-0379-9
- https://doi.org//10.1158/2326-6066.CIR-14-0154
- https://doi.org//10.1126/sciimmunol.aal2568
- https://doi.org//10.4049/jimmunol.168.8.4231
- https://doi.org//10.1158/1078-0432.CCR-16-1708
- https://doi.org//10.1158/0008-5472.CAN-10-2693
- https://doi.org//10.1007/s00262-018-2152-x
- https://doi.org//10.1080/2162402X.2017.1346764
- https://doi.org//10.1172/jci.insight.122092
- https://doi.org//10.1126/science.aaa3828
- https://doi.org//10.1080/2162402X.2017.1372081
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity